These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6367741)

  • 21. Vacuolating cytotoxin produced by avian pathogenic Escherichia coli.
    Salvadori MR; Yano T; Carvalho HE; Parreira VR; Gyles CL
    Avian Dis; 2001; 45(1):43-51. PubMed ID: 11332498
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purified colicin as cytotoxic agent of neoplasia: comparative study with crude colicin.
    Farkas-Himsley H; Yu H
    Cytobios; 1985; 42(167-168):193-207. PubMed ID: 3891240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of cytotoxic factors of Yersinia pseudotuberculosis using the MDBK cell line.
    el-Sukhon SN; Abu-Harfeil N
    Cytobios; 1998; 94(375):15-23. PubMed ID: 9853366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and purification of the active soluble form of Bacillus sphaericus binary toxin for structural analysis.
    Srisucharitpanit K; Inchana P; Rungrod A; Promdonkoy B; Boonserm P
    Protein Expr Purif; 2012 Apr; 82(2):368-72. PubMed ID: 22381463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification and cytotoxic properties of Bacillus cereus hemolysin II.
    Andreeva ZI; Nesterenko VF; Yurkov IS; Budarina ZI; Sineva EV; Solonin AS
    Protein Expr Purif; 2006 May; 47(1):186-93. PubMed ID: 16380268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification and characterization of Escherichia coli heat-stable enterotoxin II.
    Fujii Y; Hayashi M; Hitotsubashi S; Fuke Y; Yamanaka H; Okamoto K
    J Bacteriol; 1991 Sep; 173(17):5516-22. PubMed ID: 1885528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification and characterization of the recombinant 5 S subunit of transcarboxylase from Escherichia coli.
    Xie Y; Shenoy BC; Magner WJ; Hejlik DP; Samols D
    Protein Expr Purif; 1993 Oct; 4(5):456-64. PubMed ID: 8251758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Isolation and characterization of erythrogenic toxins. VII. Study of the erythrogenic toxin type C produced by Streptococcus pyogenes].
    Ozegowski JH; Knöll H; Gerlach D; Köhler W
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):38-50. PubMed ID: 6431714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification and characterization of Bacillus thuringiensis var. tenebrionis insecticidal proteins produced in E. coli.
    MacIntosh SC; McPherson SL; Perlak FJ; Marrone PG; Fuchs RL
    Biochem Biophys Res Commun; 1990 Jul; 170(2):665-72. PubMed ID: 2116794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimised expression in Escherichia coli and purification of the functional form of the Bacillus thuringiensis Cry4Aa delta-endotoxin.
    Boonserm P; Pornwiroon W; Katzenmeier G; Panyim S; Angsuthanasombat C
    Protein Expr Purif; 2004 Jun; 35(2):397-403. PubMed ID: 15135419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification and characterization of a complex between cloacin and its immunity protein isolated from Enterobacter cloacae (Clo DF13). Dissociation and reconstitution of the complex.
    De Graaf FK; Klaasen-Boor P
    Eur J Biochem; 1977 Feb; 73(1):107-14. PubMed ID: 402267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular mechanisms of action of bacterial protein toxins.
    Menestrina G; Schiavo G; Montecucco C
    Mol Aspects Med; 1994; 15(2):79-193. PubMed ID: 7984032
    [No Abstract]   [Full Text] [Related]  

  • 33. Cytotoxicity of a novel lipid-like bacterial product.
    Keler T; Kovats E; Nguyen V; Samu J; Sanavi F; Somlyo B; Nowotny A
    Biochem Biophys Res Commun; 1987 Dec; 149(3):1033-41. PubMed ID: 3322284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of cultured cell growth by high-molecular-weight material extracted from Actinomyces israelii [proceedings].
    Lyons I; Duguid R
    Biochem Soc Trans; 1980 Feb; 8(1):137-8. PubMed ID: 7371921
    [No Abstract]   [Full Text] [Related]  

  • 35. Changes in HeLa cell proliferation rate and cell surface components.
    Lotan R; Kramer RH; Nicolson GL
    Ann N Y Acad Sci; 1981 Feb; 359():407-9. PubMed ID: 6942690
    [No Abstract]   [Full Text] [Related]  

  • 36. C910 chemical compound inhibits the traffiking of several bacterial AB toxins with cross-protection against influenza virus.
    Wu Y; Mahtal N; Paillares E; Swistak L; Sagadiev S; Acharya M; Demeret C; Werf SV; Guivel-Benhassine F; Schwartz O; Petracchini S; Mettouchi A; Caramelle L; Couvineau P; Thai R; Barbe P; Keck M; Brodin P; Machelart A; Sencio V; Trottein F; Sachse M; Chicanne G; Payrastre B; Ville F; Kreis V; Popoff MR; Johannes L; Cintrat JC; Barbier J; Gillet D; Lemichez E
    iScience; 2022 Jul; 25(7):104537. PubMed ID: 35769882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Cytotoxic Necrotizing Factors (CNFs)-A Family of Rho GTPase-Activating Bacterial Exotoxins.
    Chaoprasid P; Dersch P
    Toxins (Basel); 2021 Dec; 13(12):. PubMed ID: 34941738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diversity of Virulence Genes in Multidrug Resistant
    Li X; Luo Q; Yu X; Zhang Y; Cao X; Li D
    Infect Drug Resist; 2019; 12():3817-3826. PubMed ID: 31824179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and pathologic effects of colibactin and cytotoxic necrotizing factor-1 (Cnf 1) in
    Morgan RN; Saleh SE; Farrag HA; Aboulwafa MM
    Gut Pathog; 2019; 11():22. PubMed ID: 31139264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Virulence gene profiles and molecular genetic characteristics of diarrheagenic
    Li D; Shen M; Xu Y; Liu C; Wang W; Wu J; Luo X; Jia X; Ma Y
    Gut Pathog; 2018; 10():35. PubMed ID: 30127859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.